Nura Bio Secures $68 Million Funding for Neuroprotective SARM1 Inhibitor Development
Funding Amount:
Nura Bio has secured $68 million in funding to continue its work on a neuroprotective SARM1 inhibitor.
Purpose:
The funding will be used to advance the development of the SARM1 inhibitor, which aims to provide neuroprotection.
Previous Funding:
Nura Bio was previously backed by $73 million to discover and develop neuroprotective drugs.
Product Focus:
The specific product in focus is NB-4746, a neuroprotective SARM1 inhibitor.
Date of Announcement:
The funding was announced on September 17, 2024.